Journal article
Autoantibody-mediated diseases of the CNS: Structure, dysfunction and therapy
- Abstract:
-
The field of neuronal autoantibody associated diseases of the central nervous system has expanded dramatically in the last few years. The range of identified neuronal and glial antibody targets has led to the accurate classification of a number of syndromes which each associate with characteristic clinical features. These diseases are especially important due to their frequent response to immunotherapies. Antibodies against the N-methyl, D-aspartate receptor (NMDAR) and leucine-rich glioma in...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 1.1MB)
-
- Publisher copy:
- 10.1016/j.neuropharm.2017.04.046
Authors
Funding
Bibliographic Details
- Publisher:
- Elsevier Publisher's website
- Journal:
- Neuropharmacology Journal website
- Volume:
- 132
- Pages:
- 71-82
- Publication date:
- 2017-05-01
- Acceptance date:
- 2017-04-29
- DOI:
- EISSN:
-
1873-7064
- ISSN:
-
0028-3908
Item Description
- Keywords:
- Pubs id:
-
pubs:692167
- UUID:
-
uuid:e73db6fe-62aa-49f3-82ed-b3bfbee71ea5
- Local pid:
- pubs:692167
- Source identifiers:
-
692167
- Deposit date:
- 2017-05-03
Terms of use
- Copyright holder:
- Irani et al
- Copyright date:
- 2017
- Notes:
- © 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record